CN110267657B - 氨基甲酸酯化合物用于预防、缓解或治疗震颤或震颤综合征的用途 - Google Patents
氨基甲酸酯化合物用于预防、缓解或治疗震颤或震颤综合征的用途 Download PDFInfo
- Publication number
- CN110267657B CN110267657B CN201780077642.3A CN201780077642A CN110267657B CN 110267657 B CN110267657 B CN 110267657B CN 201780077642 A CN201780077642 A CN 201780077642A CN 110267657 B CN110267657 B CN 110267657B
- Authority
- CN
- China
- Prior art keywords
- tremor
- syndrome
- use according
- essential
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170225 | 2016-12-14 | ||
| KR10-2016-0170225 | 2016-12-14 | ||
| PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110267657A CN110267657A (zh) | 2019-09-20 |
| CN110267657B true CN110267657B (zh) | 2022-12-13 |
Family
ID=62558966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780077642.3A Active CN110267657B (zh) | 2016-12-14 | 2017-12-14 | 氨基甲酸酯化合物用于预防、缓解或治疗震颤或震颤综合征的用途 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11033531B2 (enExample) |
| EP (1) | EP3556364B1 (enExample) |
| JP (1) | JP7086076B2 (enExample) |
| KR (1) | KR102635941B1 (enExample) |
| CN (1) | CN110267657B (enExample) |
| AU (1) | AU2017374459B2 (enExample) |
| CA (1) | CA3046300A1 (enExample) |
| CL (1) | CL2019001623A1 (enExample) |
| ES (1) | ES3039979T3 (enExample) |
| IL (1) | IL267191B2 (enExample) |
| MX (1) | MX391363B (enExample) |
| MY (1) | MY198417A (enExample) |
| WO (1) | WO2018111009A1 (enExample) |
| ZA (1) | ZA201903749B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102739580B1 (ko) * | 2017-11-14 | 2024-12-06 | 에스케이바이오팜 주식회사 | 후기 나트륨 전류의 증가와 관련된 질환을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| ES2978226T3 (es) * | 2018-09-21 | 2024-09-09 | Sk Biopharmaceuticals Co Ltd | Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100858232B1 (ko) * | 2001-02-27 | 2008-09-12 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 카바메이트 화합물을 포함하는 거동 장애 예방 또는 치료용 약제학적 조성물 |
| EP1732564A1 (en) * | 2004-03-29 | 2006-12-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| DK2114393T3 (da) * | 2007-03-05 | 2013-07-08 | Indus Biotech Private Ltd | Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil |
| JP5683580B2 (ja) * | 2009-06-22 | 2015-03-11 | エスケー バイオファーマシューティカル カンパニー リミテッド | カルバミン酸（ｒ）−１−アリール−２−テトラゾリル−エチルエステルの製造方法 |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| KR101717872B1 (ko) * | 2013-03-12 | 2017-03-17 | (주)바이오팜솔루션즈 | 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물 |
| KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko not_active Ceased
- 2017-12-14 MY MYPI2019003351A patent/MY198417A/en unknown
- 2017-12-14 CA CA3046300A patent/CA3046300A1/en active Pending
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 EP EP17880232.8A patent/EP3556364B1/en active Active
- 2017-12-14 ES ES17880232T patent/ES3039979T3/es active Active
- 2017-12-14 MX MX2019006941A patent/MX391363B/es unknown
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active Active
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY198417A (en) | 2023-08-29 |
| AU2017374459A1 (en) | 2019-07-04 |
| WO2018111009A1 (ko) | 2018-06-21 |
| ZA201903749B (en) | 2022-01-26 |
| IL267191A (enExample) | 2019-07-31 |
| AU2017374459B2 (en) | 2023-04-27 |
| ES3039979T3 (en) | 2025-10-28 |
| IL267191B1 (en) | 2023-01-01 |
| JP7086076B2 (ja) | 2022-06-17 |
| BR112019012000A2 (pt) | 2019-10-29 |
| MX391363B (es) | 2025-03-21 |
| US20190336481A1 (en) | 2019-11-07 |
| KR102635941B1 (ko) | 2024-02-13 |
| EP3556364A4 (en) | 2020-06-17 |
| MX2019006941A (es) | 2019-09-06 |
| CN110267657A (zh) | 2019-09-20 |
| CL2019001623A1 (es) | 2019-08-23 |
| JP2020502137A (ja) | 2020-01-23 |
| IL267191B2 (en) | 2023-05-01 |
| EP3556364B1 (en) | 2025-08-27 |
| RU2019121914A (ru) | 2021-01-15 |
| KR20190087573A (ko) | 2019-07-24 |
| RU2019121914A3 (enExample) | 2021-04-21 |
| CA3046300A1 (en) | 2018-06-21 |
| EP3556364A1 (en) | 2019-10-23 |
| US11033531B2 (en) | 2021-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11116773B2 (en) | Method of treating dementia | |
| CN113924098A (zh) | 治疗精神障碍、行为障碍、认知障碍的方法 | |
| ES2426008T5 (es) | Tratamiento de síntomas de la enfermedad de Parkinson con ligandos del receptor de histamina H3 de alquilaminas no imidazólicas | |
| EP1154795A1 (en) | Method of treating and diagnosing restless legs syndrome and corresponding means | |
| CN110267657B (zh) | 氨基甲酸酯化合物用于预防、缓解或治疗震颤或震颤综合征的用途 | |
| JP7578747B2 (ja) | 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用 | |
| RU2751504C2 (ru) | Применение карбамата для предупреждения или лечения невралгии тройничного нерва | |
| CN110290788A (zh) | 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途 | |
| KR102693607B1 (ko) | 하지 불안 증후군을 치료하기 위한 치료제 | |
| HK40015061B (en) | Use of carbamate compounds for preventing, alleviating, or treating tremors or tremor syndrome | |
| RU2776368C2 (ru) | Применение карбаматного соединения для профилактики, облегчения или лечения треморов или синдрома тремора | |
| HK40015061A (en) | Use of carbamate compounds for preventing, alleviating, or treating tremors or tremor syndrome | |
| TWI856977B (zh) | 胺基甲酸酯化合物及包括該化合物之組合於預防、緩解或治療急性壓力症或創傷後壓力症之用途 | |
| EP3556363B1 (en) | Use of carbamate compound for prevention, alleviation or treatment of pruritus | |
| BR112019012000B1 (pt) | Uso de um composto de carbamato | |
| HK40015213A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| JP2010518052A (ja) | 性機能障害の予防および治療に有用な薬物の調製のための、ニューロキニンａのｎｋ２受容体に対する化合物である拮抗薬の使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40015061 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |